
NanoTalks
- Miguel Ángel Esteve & Cristianne Rijcken
- 28/04/2026
Active Targeting in LNPs: Why Surface Functionalization Matters
Explore how active targeting strategies define the specificity, efficiency, and translational potential of lipid nanoparticle-based therapies.
This article examines how key factors such as surface functionalization, ligand conjugation strategies, and shielding lipid design directly impact targeting performance, cellular uptake, and biological outcomes. It also explores how advanced conjugation technologies, such as CliCr®, enable controlled and scalable functionalization of LNPs, supporting the development of targeted nanoparticle systems from early research to GMP-ready processes.
Recent Articles
- Filter by:
- All
- LNP
- Polymers
- Analytics
- Regulatory
- Miguel Ángel Esteve
- May 19, 2025
- Miguel Ángel Esteve
- April 29, 2025
- Elena Gallon
- April 8, 2025
- Miguel Ángel Esteve
- March 20, 2025
- Miguel Ángel Esteve
- March 11, 2025
- Miguel Ángel Esteve
- March 4, 2025
- Miguel Ángel Esteve
- February 10, 2025
- Miguel Ángel Esteve
- February 10, 2025
Sign Up for NanoTalks
Subscribe to NanoTalks, the magazine of Curapath. Stay up to date on the latest developments, trends and news in the world of non-viral vectors, plus discover the latest advances in nanobiotechnology.
